bpc 157/tb500 blend BPC-157 + TB-500 Peptide Blend TB-500 10mg / BPC-157 10mg
Description
10.1111/mmi.14332
Consistent dosing: No worrying about inconsistent pill absorption or missed doses
Potentiation of anti-myeloma activity of daratumumab with combination of cyclophosphamide, lenalidomide or bortezomib via a tumor secretory response that greatly augments macrophage-induced ADCP
Its much broader, systemic signaling profile perfectly complements the highly localized, cytoprotective repair pathways traditionally associated with Body Protection Compound-157
